Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

255 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Autophagy as a target for anticancer therapy.
Janku F, McConkey DJ, Hong DS, Kurzrock R. Janku F, et al. Nat Rev Clin Oncol. 2011 May 17;8(9):528-39. doi: 10.1038/nrclinonc.2011.71. Nat Rev Clin Oncol. 2011. PMID: 21587219 Review.
Response of histiocytoses to imatinib mesylate: fire to ashes.
Janku F, Amin HM, Yang D, Garrido-Laguna I, Trent JC, Kurzrock R. Janku F, et al. J Clin Oncol. 2010 Nov 1;28(31):e633-6. doi: 10.1200/JCO.2010.29.9073. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733125 No abstract available.
Novel therapeutic targets in non-small cell lung cancer.
Janku F, Garrido-Laguna I, Petruzelka LB, Stewart DJ, Kurzrock R. Janku F, et al. J Thorac Oncol. 2011 Sep;6(9):1601-12. doi: 10.1097/JTO.0b013e31822944b3. J Thorac Oncol. 2011. PMID: 21849857 Review.
A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignancies.
Moroney JW, Schlumbrecht MP, Helgason T, Coleman RL, Moulder S, Naing A, Bodurka DC, Janku F, Hong DS, Kurzrock R. Moroney JW, et al. Among authors: janku f. Clin Cancer Res. 2011 Nov 1;17(21):6840-6. doi: 10.1158/1078-0432.CCR-11-0666. Epub 2011 Sep 2. Clin Cancer Res. 2011. PMID: 21890452 Free PMC article. Clinical Trial.
255 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page